Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective Validation Obtained in a Similar Group of Patients and with Similar High Throughput Biological Tests Failed to Confirm Signatures for Prediction of Response to Chemotherapy and Survival in Advanced NSCLC: A Prospective Study from the European Lung Cancer Working Party.
Berghmans T, Ameye L, Lafitte JJ, Colinet B, Cortot A, CsToth I, Holbrechts S, Lecomte J, Mascaux C, Meert AP, Paesmans M, Richez M, Scherpereel A, Tulippe C, Willems L, Dernies T, Leclercq N, Sculier JP; European Lung Cancer Working Party. Berghmans T, et al. Among authors: lecomte j. Front Oncol. 2015 Jan 28;4:386. doi: 10.3389/fonc.2014.00386. eCollection 2014. Front Oncol. 2015. PMID: 25674536 Free PMC article.
A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer.
Berghmans T, Scherpereel A, Meert AP, Giner V, Lecomte J, Lafitte JJ, Leclercq N, Paesmans M, Sculier JP; European Lung Cancer Working Party (ELCWP). Berghmans T, et al. Among authors: lecomte j. Front Oncol. 2017 Sep 19;7:217. doi: 10.3389/fonc.2017.00217. eCollection 2017. Front Oncol. 2017. PMID: 28975084 Free PMC article.
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
Sculier JP, Paesmans M, Thiriaux J, Lecomte J, Bureau G, Giner V, Efremidis A, Lafitte JJ, Berchier MC, Alexopoulos CG, Zacharias C, Mommen P, Ninane V, Klastersky J. Sculier JP, et al. Among authors: lecomte j. J Clin Oncol. 1998 Apr;16(4):1388-96. doi: 10.1200/JCO.1998.16.4.1388. J Clin Oncol. 1998. PMID: 9552042 Clinical Trial.
A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer.
Sculier JP, Lafitte JJ, Lecomte J, Berghmans T, Thiriaux J, Florin MC, Efremidis A, Alexopoulos CG, Recloux P, Ninane V, Mommen P, Paesmans M, Klastersky J; European Lung Cancer Working Party. Sculier JP, et al. Among authors: lecomte j. Ann Oncol. 2002 Jun;13(6):874-82. doi: 10.1093/annonc/mdf154. Ann Oncol. 2002. PMID: 12123332 Free article. Clinical Trial.
A phase II randomised trial comparing the cisplatin-etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer.
Sculier JP, Lafitte JJ, Lecomte J, Berghmans T, Thiriaux J, Van Cutsem O, Efremidis A, Ninane V, Paesmans M, Mommen P, Klastersky J; European lung cancer working party. Sculier JP, et al. Among authors: lecomte j. Ann Oncol. 2002 Sep;13(9):1454-9. doi: 10.1093/annonc/mdf244. Ann Oncol. 2002. PMID: 12196372 Free article. Clinical Trial.
A phase III randomised study comparing two different dose-intensity regimens as induction chemotherapy followed by thoracic irradiation in patients with advanced locoregional non-small-cell lung cancer.
Sculier JP, Lafitte JJ, Berghmans T, Van Houtte P, Lecomte J, Thiriaux J, Efremidis A, Koumakis G, Giner V, Richez M, Corhay JL, Wackenier P, Lothaire P, Paesmans M, Mommen P, Ninane V; European Lung Cancer Working Party. Sculier JP, et al. Among authors: lecomte j. Ann Oncol. 2004 Mar;15(3):399-409. doi: 10.1093/annonc/mdh105. Ann Oncol. 2004. PMID: 14998841 Free article. Clinical Trial.
A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer.
Sculier JP, Lafitte JJ, Lecomte J, Alexopoulos CG, Van Cutsem O, Giner V, Efremidis A, Berchier MC, Collon T, Meert AP, Scherpereel A, Ninane V, Paesmans M, Berghmans T; European Lung Cancer Working Party. Sculier JP, et al. Among authors: lecomte j. Ann Oncol. 2007 Jun;18(6):1037-42. doi: 10.1093/annonc/mdm084. Epub 2007 Apr 2. Ann Oncol. 2007. PMID: 17404152 Free article. Clinical Trial.
Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party.
Berghmans T, Lafitte JJ, Lecomte J, Alexopoulos CG, Van Cutsem O, Giner V, Efremidis A, Berchier MC, Collon T, Meert AP, Scherpereel A, Ninane V, Leclercq N, Paesmans M, Sculier JP; European Lung Cancer Working Party. Berghmans T, et al. Among authors: lecomte j. Br J Cancer. 2007 Jun 4;96(11):1644-9. doi: 10.1038/sj.bjc.6603772. Epub 2007 May 1. Br J Cancer. 2007. PMID: 17473825 Free PMC article. Clinical Trial.
1,217 results